Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

2.

Neoadjuvant hormonal therapy in carcinoma of the prostate.

Lee HH, Warde P, Jewett MA.

BJU Int. 1999 Mar;83(4):438-48. Review.

PMID:
10210568
3.

Neoadjuvant hormone therapy: the Canadian trials.

Klotz L, Gleave M, Goldenberg SL.

Mol Urol. 2000 Fall;4(3):233-7;discussion 239. Review.

PMID:
11062379
4.
6.

Neoadjuvant hormonal therapy in the management of prostate cancer: a surgical and radiation therapy review.

Soderdahl DW, Wettlaufer JN, Corn B, Gomella LG.

Tech Urol. 1996 Winter;2(4):194-206. Review.

PMID:
9085540
7.

Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.

Saad M, Abdel-Rahim M, Abol-Enein H, Ghoneim MA.

BJU Int. 2008 Dec;102(11):1544-50. doi: 10.1111/j.1464-410X.2008.07831.x. Epub 2008 Jun 19. Review.

8.

Morphological changes induced by androgen blockade in normal prostate and prostatic carcinoma.

Têtu B.

Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):271-83. doi: 10.1016/j.beem.2008.01.005. Review.

PMID:
18471785
9.

Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia.

Bostwick DG, Qian J.

Urology. 2001 Aug;58(2 Suppl 1):91-3. Review.

PMID:
11502458
10.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
11.

Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experience.

Fair WR, Scher HI.

Surg Oncol Clin N Am. 1997 Oct;6(4):831-46. Review.

PMID:
9309096
12.
13.

Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report.

Bostwick DG, Montironi R, Sesterhenn IA.

Scand J Urol Nephrol Suppl. 2000;(205):3-10. Review.

PMID:
11144902
14.

[Neoadjuvant hormonal therapy for prostate cancer].

Miki T, Kamoi K.

Gan To Kagaku Ryoho. 2001 Jul;28(7):927-33. Review. Japanese.

PMID:
11478141
15.

Prostatic intraepithelial neoplasia and prostate cancer.

Montironi R, Santinelli A, Mazzucchelli R.

Panminerva Med. 2002 Sep;44(3):213-20. Review.

PMID:
12094135
16.

[Application and limitation of neoadjuvant hormonal therapy for prostate cancer].

Demura T, Shinohara N, Nonomura K, Koyanagi T.

Nihon Rinsho. 1998 Aug;56(8):2150-6. Review. Japanese.

PMID:
9750525
17.

Use of neoadjuvant androgen deprivation therapy in clinically localized prostate cancer.

Fair WR, Aprikian AG, Cohen D, Sogani P, Reuter V.

Clin Invest Med. 1993 Dec;16(6):516-22. Review.

PMID:
8013156
18.

The morphologic changes induced by hormone and radiation therapy on prostate carcinoma.

Roznovanu SL, Rădulescu D, Novac C, Stolnicu S.

Rev Med Chir Soc Med Nat Iasi. 2005 Apr-Jun;109(2):337-42. Review.

PMID:
16607796
19.

Intermediate biomarkers for chemoprevention of prostate cancer.

van der Kwast TH.

IARC Sci Publ. 2001;154:199-205. Review.

PMID:
11220659
20.

Diagnosis of prostatic carcinoma after therapy.

Bostwick DG, Meiers I.

Arch Pathol Lab Med. 2007 Mar;131(3):360-71. Review.

PMID:
17516739

Supplemental Content

Support Center